First published · Last updated
Adamantane-based scaffolds: Synthesis, DFT, docking and potential as anticancer agents via CDC25A inhibition
A journal article published 2027-02-01 reports synthesis, computational (DFT) and docking studies of adamantane-based scaffolds and suggests they have potential as anticancer agents through CDC25A inhibition. The supplied source fields include only the article metadata and title without additional experimental or outcome details.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 2/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 2/10
- Positivity
- 7/10
- Urgency
- 1/10
Why it matters
The study identifies molecules proposed to inhibit CDC25A, a target linked to cancer therapy research.

